Page last updated: 2024-08-24

fozivudine tidoxil and HIV Coinfection

fozivudine tidoxil has been researched along with HIV Coinfection in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anglaret, X; Danel, C; Eholie, S; Ello, F; Girard, PM; Hoelscher, M; Kroidl, A; Lennemann, T; Maganga, L; Mgaya, J; Moh, R; Pruvost, A; Saathoff, E; von Massow, F; Zuhse, R1
Anderson, R; Boerner, D; Diquet, B; Girard, PM; Pegram, PS; Raffi, F; Sereni, D; Tubiana, R1
Boerner, D; Bogner, JR; Goebel, FD; Herrmann, DB; Hoegl, L; Jost, V; Mühlhöfer, A; Roecken, M; Thoma-Greber, E1
Boerner, D; Bogner, JR; Goebel, FD; Gürtler, L; Herrmann, DB; Kaufmann, B; Plewig, G; Roecken, M1

Reviews

1 review(s) available for fozivudine tidoxil and HIV Coinfection

ArticleYear
Fozivudine: BM 211290, fozivudine tidoxil, FZT, HDP 990002, W 09726867.
    Drugs in R&D, 2004, Volume: 5, Issue:1

    Topics: Animals; Anti-HIV Agents; Drugs, Investigational; HIV Infections; Humans; Lipids; Zidovudine

2004

Trials

4 trial(s) available for fozivudine tidoxil and HIV Coinfection

ArticleYear
Virological efficacy of 24-week fozivudine-based regimen in ART-naive patients from Tanzania and Côte d'Ivoire.
    AIDS (London, England), 2017, 02-20, Volume: 31, Issue:4

    Topics: Adult; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Cote d'Ivoire; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; Humans; Lipids; Male; Middle Aged; Prospective Studies; Sustained Virologic Response; Tanzania; Treatment Outcome; Zidovudine

2017
Phase II placebo-controlled trial of fozivudine tidoxil for HIV infection: pharmacokinetics, tolerability, and efficacy.
    Journal of acquired immune deficiency syndromes (1999), 2000, Mar-01, Volume: 23, Issue:3

    Topics: Adult; Anti-HIV Agents; Area Under Curve; Dose-Response Relationship, Drug; Double-Blind Method; Female; HIV Infections; HIV-1; Humans; Lipids; Male; Reverse Transcriptase Inhibitors; RNA, Viral; Viral Load; Zidovudine

2000
Single dose, dose-escalating trial with fozivudine tidoxil (BM 21.1290).
    Antiviral therapy, 1997, Volume: 2, Issue:4

    Topics: Adult; Anti-HIV Agents; Food; HIV Infections; Humans; Lipids; Male; Middle Aged; Zidovudine

1997
Phase I/II trial with fozivudine tidoxil (BM 21.1290): a 7 day randomized, placebo-controlled dose-escalating trial.
    Antiviral therapy, 1997, Volume: 2, Issue:4

    Topics: Adult; Anti-HIV Agents; HIV Infections; Humans; Lipids; Male; Middle Aged; RNA, Viral; Zidovudine

1997